Prenosis
Prenosis, Inc.: A US-based precision medicine firm using machine learning to predict patient outcomes.
Founded
2014Prenosis, Inc.: A US-based precision medicine firm using machine learning to predict patient outcomes.
Founded in Champaign, Illinois, Prenosis, Inc. is a precision medicine company dedicated to revolutionizing acute care through personalized healthcare solutions. The company's core mission is to tailor healthcare to individual biological profiles using advanced machine learning algorithms. Prenosis offers products like the Immunix™ precision medicine platform and the Sepsis ImmunoScore™, which predict patient outcomes based on historical patient data. Their market focus is primarily on the United States, aiming to enhance patient care through predictive analytics.
Prenosis has garnered attention with its FDA De Novo authorization for the Sepsis ImmunoScore™, marking a significant milestone in medical diagnostics. The company collaborates with leading healthcare professionals and institutions to refine its technology. Notable investors and affiliated individuals include experts in machine learning and healthcare innovation, contributing to Prenosis's growing impact in precision medicine. The company's achievements underscore its potential to transform acute care by providing more accurate and personalized treatment options.
Companies similar to Prenosis include PreSquared, Prenovo, Presaj and PredxBio.
Prenosis was founded in 2014.
Prenosis' headquarters is located in Chicago, IL, US.
Prenosis' most recent funding round was for $4.8M (USD) in July 2023.
As of Jul 12, 2023, Prenosis has disclosed funding of $11.5M (USD). Undisclosed round amounts are excluded.
Prenosis has 35 employees as of Feb 5, 2024.
predxbio.com
